GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $388,000 | -69.9% | 8,000 | -67.3% | 0.00% | -60.0% |
| Q2 2019 | $1,289,000 | +10.7% | 24,500 | +11.4% | 0.01% | 0.0% |
| Q1 2019 | $1,164,000 | +23.3% | 22,000 | -4.3% | 0.01% | +25.0% |
| Q4 2018 | $944,000 | +12.9% | 23,000 | +4.5% | 0.00% | +33.3% |
| Q3 2018 | $836,000 | -41.8% | 22,000 | -30.8% | 0.00% | -50.0% |
| Q2 2018 | $1,437,000 | +272.3% | 31,788 | +297.4% | 0.01% | +200.0% |
| Q1 2018 | $386,000 | +315.1% | 8,000 | +166.7% | 0.00% | – |
| Q3 2017 | $93,000 | -32.1% | 3,000 | -40.0% | 0.00% | -100.0% |
| Q2 2017 | $137,000 | -76.8% | 5,000 | -68.8% | 0.00% | -66.7% |
| Q1 2017 | $590,000 | +241.0% | 16,000 | +33.3% | 0.00% | +200.0% |
| Q4 2016 | $173,000 | -60.5% | 12,000 | -36.8% | 0.00% | -50.0% |
| Q3 2016 | $438,000 | +55.3% | 19,000 | +11.8% | 0.00% | +100.0% |
| Q2 2016 | $282,000 | -45.7% | 17,000 | +5.9% | 0.00% | -66.7% |
| Q4 2015 | $519,000 | -31.1% | 16,050 | -10.1% | 0.00% | -25.0% |
| Q3 2015 | $753,000 | – | 17,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |